» Articles » PMID: 33847389

Pharmacogenomics and Morphine

Overview
Publisher Wiley
Specialty Pharmacology
Date 2021 Apr 13
PMID 33847389
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Morphine is an opioid analgesic indicated in the treatment of acute and chronic moderate to severe pain. From a pharmacodynamic standpoint, morphine exerts its effects by agonizing mu-opioid receptors predominantly, resulting in analgesia and sedation. Pharmacokinetically, morphine is primarily metabolized in the liver via glucuronidation by the enzyme uridine diphosphate glucuronosyltransferase family 2 member B7 and encounters the transporter proteins organic cation transporter isoform 1 and P-glycoprotein (adenosine triphosphate-binding cassette subfamily B member 1) as it is being distributed throughout the body. The genes coding for the proteins impacting either the pharmacokinetics or pharmacodynamics of morphine may bear genetic variations, also known as polymorphisms, which may alter the function of the proteins in such a manner that an individual may have disparate treatment outcomes. The purpose of this review is to highlight some of the genes coding for proteins that impact morphine pharmacokinetics and pharmacodynamics and present some treatment considerations.

Citing Articles

Different doses of epidural morphine combined with multimodal analgesia strategies for postpartum pain management: study protocol for a single-centre, double-blind randomised, pragmatic clinical trial.

Yu R, Lin X BMJ Open. 2024; 14(12):e085012.

PMID: 39658300 PMC: 11647343. DOI: 10.1136/bmjopen-2024-085012.


Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway.

Ning J, Chen X, Li Q, Yang D, Xie C, Qin S Sci Rep. 2024; 14(1):24233.

PMID: 39414944 PMC: 11484833. DOI: 10.1038/s41598-024-75089-7.


Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.

Guengerich F Pharmacol Rev. 2024; 76(6):1104-1132.

PMID: 39054072 PMC: 11549934. DOI: 10.1124/pharmrev.124.001173.


Unraveling the protective effects of curcumin against drugs of abuse.

Soltaninejad M, Saboori Amleshi R, Shabani M, Ilaghi M Heliyon. 2024; 10(9):e30468.

PMID: 38726155 PMC: 11079105. DOI: 10.1016/j.heliyon.2024.e30468.


Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Gambari R, Waziri A, Goonasekera H, Peprah E Int J Mol Sci. 2024; 25(8).

PMID: 38673849 PMC: 11050010. DOI: 10.3390/ijms25084263.


References
1.
Chatti I, Woillard J, Mili A, Creveaux I, Ben Charfeddine I, Feki J . Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment. Iran J Public Health. 2017; 46(12):1704-1711. PMC: 5734971. View

2.
Hu B, Zhang X, Xu G, Zhang Q, Qian P, Liu S . Association between COMT Polymorphism Val158Met and Opioid Consumption in Patients with Postoperative Pain: A Meta-Analysis. Neurosignals. 2018; 26(1):11-21. DOI: 10.1159/000487038. View

3.
Tzvetkov M, Dos Santos Pereira J, Meineke I, Saadatmand A, Stingl J, Brockmoller J . Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol. 2013; 86(5):666-78. DOI: 10.1016/j.bcp.2013.06.019. View

4.
PICO L, Hernot S, Negre I, Samii K, Fletcher D . Peroperative titration of morphine improves immediate postoperative analgesia after total hip arthroplasty. Can J Anaesth. 2000; 47(4):309-14. DOI: 10.1007/BF03020943. View

5.
Peterkin V, Bauman J, Goosen T, Menning L, Man M, Paulauskis J . Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes. Br J Clin Pharmacol. 2007; 64(4):458-68. PMC: 2048551. DOI: 10.1111/j.1365-2125.2007.02923.x. View